Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SLC7A5 anticorps

SLC7A5 Reactivité: Humain IHC Hôte: Souris Monoclonal 4D9 unconjugated
N° du produit ABIN289955
  • Antigène Voir toutes SLC7A5 Anticorps
    SLC7A5 (Solute Carrier Family 7 (Cationic Amino Acid Transporter, Y+ System), Member 5 (SLC7A5))
    Reactivité
    • 32
    • 17
    • 16
    • 15
    • 3
    • 3
    • 2
    • 2
    • 2
    Humain
    Hôte
    • 30
    • 2
    • 1
    Souris
    Clonalité
    • 30
    • 3
    Monoclonal
    Conjugué
    • 19
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp SLC7A5 est non-conjugé
    Application
    • 24
    • 13
    • 8
    • 6
    • 6
    • 5
    • 2
    • 1
    Immunohistochemistry (IHC)
    Purification
    The spleen cells from mouse, immunized with the synthesized peptide of human C endof LAT-1, were fused with mouse P3U1 myeloma cells. The hybridoma cell line withpositive reaction was grown in ascitic fluid of BALB/c mouse, from which theantibody was purified by Peptide affinity chromatography.
    Immunogène
    Partial peptide of Human L-type Amino Acid Transporter 1 (LAT1)
    Clone
    4D9
    Isotype
    IgM
    Top Product
    Discover our top product SLC7A5 Anticorps primaire
  • Indications d'application
    Working dilution for immunohistochemistry: 2-5ug/mlFor more detail on the immunohistochemistry, refer to the immuno staining method.
    Restrictions
    For Research Use only
  • Concentration
    0.2 mg/ml
    Buffer
    PBS (containing 0.1% BSA as a stabilizer, 0.1% Proclin as a bacteriostat)
    Agent conservateur
    ProClin
    Stock
    -20 °C
  • Antigène
    SLC7A5 (Solute Carrier Family 7 (Cationic Amino Acid Transporter, Y+ System), Member 5 (SLC7A5))
    Autre désignation
    L-type Amino Acid Transporter 1 (LAT1) (SLC7A5 Produits)
    Synonymes
    anticorps 4F2LC, anticorps CD98, anticorps D16S469E, anticorps E16, anticorps LAT1, anticorps MPE16, anticorps hLAT1, anticorps D0H16S474E, anticorps TA1, anticorps JHI-21, anticorps SLC7A5, anticorps LAT-1, anticorps slc7a5a, anticorps 4F2, anticorps 4F2HC, anticorps AI314110, anticorps Cd98, anticorps Ly-10, anticorps Ly-m10, anticorps Ly10, anticorps Mdu1, anticorps Mgp-2hc, anticorps NACAE, anticorps solute carrier family 7 member 5, anticorps solute carrier family 7 (cationic amino acid transporter, y+ system), member 5, anticorps solute carrier family 7 (amino acid transporter light chain, L system), member 5, anticorps solute carrier family 7 member 5 S homeolog, anticorps solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2, anticorps SLC7A5, anticorps Slc7a5, anticorps slc7a5.S, anticorps Slc3a2
    Sujet
    Mammalian amino acid transport system is consisted of large variety of transporters, with the reflection ofamino acid molecule variety, and is clessfied into various transport systems by the transportative substrateselectivity and the Na+ dependence with the reflection of amino acid molecule variety.L-type amino acid transporter 1 (LAT1) is a predicted 12 membrane-spanning protein and is unique because itrequires an additional single membrane spanning protein, 4F2 heavy chain (4F2hc:CD98), for its functionalexpression. L-type is Na+ -independent neutral amino acid transporter agency and essential for the transporter oflarge neutral amino acid such as Leucine, Isoleucine, Varine through the plasma membrane. LAT1 is, thustransporter responsible for the permeation of aromatic or branched-chain amino acids and amino acid-relateddrugs such as L-DOPA. LAT has been proposed to be one of the major nutrient transport systems at theblood-brain barrier. Highly regulated nature and high level of expression in tumor cell lines, LAT is thought to beup-regulated to support the high protein synthesis for cell glowth and cell activation.This antibody has been proved to be useful for the immunohistochemistry.
Vous êtes ici:
Support technique